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Abstract 
Lichenysin which is produced by 53 different Bacillus licheniformis strains has 
been structurally examined with a qualitative liquid chromatography – tandem 
mass spectrometry (LC-MS/MS) method using quadrupole – time of flight mass 
spectrometry. The same lichenysin isoforms are produced from all strains, 
indicating that the growth conditions have a stronger influence on the lipopeptide 
production than the genotype. A rapid method for the quantification of lichenysin 
from bacterial cell cultures with LC-MS/MS after a simple methanol extraction 
has been refined. For the first time, commercially available lichenysin has been 
used as calibrant, making quantification more accurate. The trueness for C15-
lichenysin has been improved to 94% using matrix-matched calibration with 
lichenysin compared to 30% using solvent calibration with surfactin. The 
quantitative method was fully validated based on Commission Decision 
2002/657/EC. The LOD of the method was below 1 µg g-1 and the repeatability 
ranged from 10% to 16%.    
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Introduction 
Bacillus licheniformis is a saprophytic soil bacterium that is widespread in nature due to 
its endospore forming properties. It is widely used in the fermentation industry in the 
production of enzymes (proteases and amylases), antibiotics (Schallmey et al. 2004) and 
probiotics (Cutting 2011). B. licheniformis is not considered a human pathogen although 
it has been isolated from several human infections, in all of which the inflicted humans 
where immunocompromised (Idelevich et al. 2013,  Lepine et al. 2009, Park et al. 
2006). The first reports of the involvement of B. licheniformis in food poisoning came 
in England in the 1970s, but the virulence factor(s) were neither detected nor described 
(Kramer and Gilbert 1989). Large amounts of B. licheniformis have been associated 
with a few cases of food poisoning (intoxications), one of which had a fatal outcome 
(Salkinoja-Salonen et al. 1999). It has also been involved in animal abortions and 
bovine mastitis where lichenysin-producing strains were detected in mastitic milk 
(Agerholm et al. 1995, Johnson et al. 1994, Nieminen et al. 2007, Syrjälä et al. 2007). 
The exact mechanism and role of B. licheniformis as causative agent of food poisoning 
is unknown, although lichenysin has been proposed as the virulence factor (From et al. 
2005, Mikkola et al. 2000, Salkinoja-Salonen et al., 1999). Toxic lichenysin was 
detected in baby milk formula associated with the death of an infant, indicating that 
lichenysin is indeed the source of food poisoning (Mikkola et al., 2000). Further 
investigations are needed to clarify the role of lichenysin in food poisoning. 
Lichenysin is a lipopeptide produced by most, if not all B. licheniformis strains 
(Madslien et al. 2013). It is an excellent surfactant and a good chelating agent for Ca2+ 
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and Mg2+ (Grangemard et al. 2001, Javaheri et al. 1985, McInerney et al. 1990). 
Lichenysin is also shown to have anti-inflammatory, antimicrobial, antitumor and 
immunosuppressive properties but is also haemolytic (Grangemard, Wallach, Maget-
Dana and Peypoux 2001). These characteristics are to a wide extent caused by the 
amphiphilic nature of the lipopeptide; it consists of a peptide moiety comprised by 
seven amino acids and a β-hydroxy fatty acid with 12 – 17 carbon atoms with possible 
normal, iso and anteiso branching (Grangemard et al. 1999, Hasumi et al. 1995, 
Horowitz and Griffin 1991, Jenny et al. 1991, Konz et al. 1999, Mikkola, Kolari, 
Andersson et al.,  2000, Trischman et al. 1994, Yakimov et al. 1999, Yakimov et al. 
1995). Several isoforms and homologues of lichenysin are found in nature, both amino 
acid substitutions and alterations in the length and branching of the fatty acid chain 
occurs. The most abundant isoform is known as lichenysin A (Figure 1) (Yakimov et 
al., 1999) where the amino acid sequence is Gln – Leu – D-Leu – Val – Asp – D-Leu – 
Ile (Konz et al., 1999, Mikkola, Kolari et al.,  2000, Yakimov et al., 1999). Surfactin, 
another lipopeptide produced by Bacillus subtilis, is very similar in structure to 
lichenysin A (Figure 1) and differ only with the substitution of glutamine with glutamic 
acid in the first amino acid position (AA1) (Konz et al., 1999, Peypoux et al. 1999). 
This small difference however, increases the surfactant properties of lichenysin 
significantly; the critical micelle concentration (CMC) is 22 µM for lichenysin and 220 
µM for surfactin, 100 % haemolysis is obtained with 15 µM lichenysin and 200 µM 
surfactin and the association constant with Ca2+ is four times higher for lichenysin than 
surfactin and 16 times higher for Mg2+ (Grangemard et al., 2001).  
Several different detection methods for lichenysin have been developed 
including cytotoxicity methods like the sperm motility assay (Andersson et al. 1998, 
Hoornstra et al. 2003) and the Vero cell assay (Sandvig and Olsnes 1982), and PCR 
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(Madslien et al., 2013, Nieminen et al., 2007, Tapi et al. 2010, Turgay and Marahiel 
1994, Wu et al. 2015). None of these methods proves the presence of lichenysin, only a 
possible effect of the lipopeptide or the genes encoding lichenysin synthetase. 
Analytical methods utilising LC-MS detect lichenysin directly by separating the analyte 
of interest from interfering matrix components both based on differences in 
hydrophobicity and molecular mass. Several qualitative mass spectrometry based 
methods have been published for the detection of lichenysin (Andersson et al., 1998, 
From et al. 2007, Grangemard et al., 1999, Guo et al. 2014, Horowitz and Griffin 1991, 
Jenny et al., 1991, Li et al. 2008, Mikkola et al. 1999, Yakimov et al., 1999, Yang et al. 
2006) but only a few quantitative methods, none of which uses commercially available 
lichenysin for calibration (Madslien et al.,  2013, Zhang et al. 2014).  
The use of Bacillus species as additives in the production of animal feed is 
regulated by the EFSA panel on additives and products or substances used in animal 
feed (FEEDAP). Until 2013 the FEEDAP scientific opinion stated that a test for 
haemolysis together with PCR screening for non-ribosomal peptide synthase genes were 
sufficient to reveal the potential of lipopeptide production in the strains of interest 
(EFSA FEEDAP Panel: Technical guidance on the assessment of the toxigenic potential 
of Bacillus species used in animal nutrition  2011). After the revelation that most, if not 
all, Bacillus licheniformis strains produces lichenysin and several strains are non-
haemolytic (Madslien et al.,  2013), together with indications of the same behaviour in 
Bacillus subtilis strains (Dybwad et al. 2012), FEEDAP endorsed the need for a revision 
of the current scientific opinion resulting in a revised scientific opinion published in 
2014 (EFSA FEEDAP Panel: Guidance on the assessment of the toxigenic potential of 
Bacillus species used in animal nutrition  2014, EFSA FEEDAP Panel: The need to 
revise the Technical Guidance on the assessment of the toxigenic potential of Bacillus 
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species used in animal nutrition  2013). It recommends that the cytotoxicity of all 
Bacillus strains (non-B. cereus) considered in feed production should be evaluated by an 
in vitro cell-based method like the Vero cell assay. In case of proven cytotoxicity is the 
strain not suitable for use as a feed additive.  
We have earlier shown that the cytotoxicity alone is insufficient as a marker for 
the lichenysin content in cell extracts (Madslien et al., 2013). The risk of illness 
resulting from the presence of lichenysin in food products is also yet to be evaluated. To 
ensure an accurate measurement of the lichenysin production from different bacterial 
strains it is therefore important not only to verify the cytotoxicity but also quantify the 
amount of lichenysin present in the cell extracts. Quantitative methods suitable for 
routinely use are necessary to enable this. To ensure an accurate quantification the 
choice of calibration and a proper validation of the method is of importance.  
In this study 53 Bacillus licheniformis strains have been qualitatively analysed to 
compare the occurrence of the different lichenysin isoforms. We have also sought to 
further improve a quantitative method to determine the lichenysin content in bacterial 
cell extracts. For the first time commercially available lichenysin has been used for 
calibration to ensure more accurate quantification. The method has been fully validated 
based on Commission Decision 657/2002.  
Materials and methods 
This method, both the sample preparation, chromatography and quantitative mass 
spectrometry, is a modified version of the one described by Madslien et al., (2013). 
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Chemicals and reagents 
All chemicals were of at least HPLC-grade and supplied by VWR (West Chester, PA, 
USA) except lichenysin A (98.2 %, Lipofabrik, Villeneuve-d’Ascq, France), surfactin 
(≥ 98 %, Sigma, Steinheim, Germany) and heptafluorobutyric acid (Fluka, Buchs, 
Switzerland). The water used was grade 1 purified with a Milli-Q water purification 
system (Millipore, Bedford, MA, USA).  
Sample preparation 
Bacterial strains were grown for 10 days at 37°C on trypticase soy agar (TSA) plates 
(Merck KGaA, Darmstadt, Germany). The biomass was collected and weighed before 
addition of 2 equivalents of methanol and homogenisation by vortex mixing for 5 min 
(VXR basic Vibrax, IKA Werk, Staufen, Germany).  Equivalents of 50 mg biomass 
were weighed in centrifuge tubes. The cells were lysed by boiling in 1 mL methanol for 
30 min, resulting in partially evaporation of the methanol. The residue was added 500 
µL methanol and vortex mixed for 3 min before centrifugation at 14 000 x g for 3 min.  
The supernatant was transferred to a 12 mL centrifuge tube and evaporated to dryness at 
80°C under a stream of air using a Pierce Reacti-Therm heating module (Pierce, 
Rockford, IL, USA). The dry residue was reconstituted in 200 µL methanol and filtered 
through a 0.22 µm nylon spin filter (Costar Spin-x, Costar, Corning Incorporated, 
Corning, NY, USA). Aliquots of 10 µL were injected on column for qualitative analysis 
and 1 µL for quantitative analysis. 
Liquid chromatography 
The instrumentation used for the qualitative analysis was an Agilent 1260 SL system 
(Agilent Technologies, Waldbronn, Germany) consisting of a binary pump, 
thermostatted autosampler kept at 4°C and column compartment kept at 35°C. The 
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separation was performed on an RRHD Zorbax Eclipse Plus C18 column, 100 x 2.1 mm 
id, with 1.8 µm particles (Agilent Technologies, Palo Alto, CA, USA). Mobile phase A 
consisted of 2 mM ammonium acetate and 0.2 % heptafluorobutyric acid in water and 
mobile phase B was acetonitrile and methanol (1+1). The flow rate was 0.3 mL/min 
with a linear gradient from 90 – 93 % B in 6 min. Total time of analysis was 12 min. 
The autosampler temperature was 4°C. 
The quantitative analysis was performed with an Agilent 1290 Infinity system 
(Agilent Technologies, Waldbronn, Germany) with the same conditions as the 
quantitative analysis only with flow rate 0.4 mL/min with a linear gradient from 90 – 93 
% B in 4 min. Total time of analysis was 8 min.   
Qualitative mass spectrometry  
The structure elucidation of lichenysin was done on a G6520 quadrupole-time of flight 
mass spectrometer (Agilent Technologies, Santa Clara, CA, USA) operated in 4 GHz, 
high resolution mode. The ionisation was done with dual electrospray in positive mode 
with reference mass correction. The fragmentor voltage was 175 V, gas temperature 
325°C, drying gas flow 5 L/min, nebulizer pressure 30 psi, capillary voltage 4000 V and 
collision energy 25 V and 35 V. The acquisition mode was targeted MS/MS in scan area 
50-1200 Da with recorded 3 spectra/s in both MS and MS/MS. The targeted list is 
shown in Table 1. The delta retention time was 2 min for all ions.    
Quantitative mass spectrometry 
Lichenysin was quantified using a G6490 triple quadrupole mass spectrometer (Agilent 
Technologies, Singapore) equipped with a Jet Stream electrospray ion source. Data was 
acquired in positive multiple reaction monitoring mode, MRM. The ion transitions 
monitored and their corresponding collision energies are listed in Table 2. Common 
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instrument settings for all ion transitions were fragmentor voltage 380 V, dwell time 20 
ms, gas flow 14 L/min, gas temperature 250°C, nebulizer pressure 20 psi, sheath gas 
flow 11 L/min, sheath gas temperature 400°C, capillary voltage 4000 V and nozzle 
voltage 0 V.   
Calibration 
Matrix matched calibration was performed by adding lichenysin at five concentration 
levels (1, 10, 50, 100 and 500 µg/mL) to biomass from Bacillus cereus strain ATCC 
14579 before the extraction.   Calibration curves of both lichenysin and surfactin in pure 
solvent (methanol/water, 3+1) were prepared for comparison with matrix matched 
calibration. Five concentration levels (1, 10, 50, 100 and 500 µg/mL) were diluted with 
methanol from a stock solution of 1 mg/mL in acetonitrile (lichenysin) or ethanol 
(surfactin).  
Validation 
Bacillus cereus strain ATCC 14579 was used as matrix for the validation samples. The 
biomass from seven plates was pooled, added a known amount of methanol and 
homogenised to a slurry by vortexing before weighing in aliquots equivalent to 50 mg 
biomass. Bacillus licheniformis strain NVH1115 was used as positive control. 
The validation of the quantitative method was done using the calibration curve 
method based on 2002/657/EC (Commission decision of 12 August 2002 implementing 
Council directive 96/23/EC concerning the performance of analytical methods and the 
interpretation of results  2002) and an interpretation thereof (Antignac et al. 2003). 
Matrix matched calibration curves were prepared by adding lichenysin at five 
concentration levels (1, 10, 50, 100, 500 µg/g) to the samples before extraction. The 
regression coefficient (R2) and the slope (a) of the calibration curve were used to assess 
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the linearity of the method together with the response factor test. The repeatability was 
evaluated by the RSD for 12 samples from three different sample sets spiked with 10 
µg/g lichenysin. The limit of detection (LoD = 3 x SDb, where SDb is the standard 
deviation of the blank signal) and limit of quantification (LoQ = 10 x SDb) assesses the 
sensitivity. The selectivity was evaluated from six negative samples. 
Determination of the recovery was done by analysing pure lichenysin standard 
(AS), matrix samples without fortification (AB), prepared matrix samples fortified 
before injection on the LC-MS/MS (AMS) and matrix samples fortified before the 
sample preparation (ASP). Both total recovery (RT = (ASP- AB)/AS), recovery in the 
sample preparation (RSP = (ASP-AB)/(AMS- AB)) and recovery of the LC-MS/MS method 
(RMS = (AMS- AB)/ AS) were established.  
The lichenysin content in 21 positive samples from Bacillus licheniformis strain 
NVH1079 was used to evaluate the homogeneity. The biomass from 18 plates were 
pooled and treated in the same way as the validation samples. 
Results and discussion 
This study was done to fully validate and elaborate the quantitative method for 
lichenysin that we first published in 2013 (Madslien et al.,  2013), as well as to confirm 
the structure of the lichenysin isoforms found by developing a qualitative LC-MS/MS 
method. The introduction of commercially available lichenysin as calibrant instead of 
surfactin has raised new methodological issues and a study of different quantification 
techniques has been applied. To ensure the validity of the quantification a validation 
study based on Commission decision 657/2002 has been applied (Commission decision 
of 12 August 2002 implementing Council directive 96/23/EC concerning the 
performance of analytical methods and the interpretation of results  2002). 
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During the validation study it became clear that the lichenysin isoform with 
precursor ion m/z 993 was not expressed as well by the bacterial strain used for the 
calibration standard (ATCC 14580) as by the strains used in the preliminary 
experiments (Madslien et al., 2013). As a consequence, only one ion transition was 
sufficiently abundant to be evaluated for m/z 993 and it was not possible to establish 
any sensible validation data due to too few calibration levels above the LOD. The ion 
transition m/z 993 – 685 has been included in the study but is only to be regarded as 
qualitative.    
Structural determination of lichenysin in cell extracts from different bacterial 
strains 
The molecular structure of lichenysin has been described in several publications during 
the last two decades and, as pointed out in the introduction, several isoforms and 
homologues of lichenysin occur in nature (Grangemard et al., 1999, Hasumi et al., 1995, 
Horowitz and Griffin 1991, Jenny et al., 1991, Konz et al., 1999, Mikkola et al., 2000, 
Trischman et al.,  1994, Yakimov et al., 1999, Yakimov et al., 1995). Different bacterial 
strains might produce different isoforms in different ratios. Whether this is 
enzymatically controlled, due to growth conditions or genetics or a combination, is not 
certain (Konz et al.,  1999). Four major isoforms of lichenysin have been separated and 
identified in this study (Figure 2). They are all detected as their protonated ions 
(M+H)+, their sodium adducts (M+Na)+ and the three most abundant are also detected 
as their 2Na adducts (M-H+2Na)+. The protonated ions are the most sensitive in the LC-
MS/MS under the optimized conditions. The molecular structure of the three major 
peaks of lichenysin (m/z 1007.7, 1021.7 and 1035.7) in extracts from 53 different B. 
licheniformis strains was investigated. More information about the strains can be found 
in Madslien et al 2013 (Madslien et al., 2013). The product ion mass spectra from m/z 
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1007.67, m/z 1021.68 A  and 1035.70 all show the same amino acid sequence with a 
good coverage of both y- and b-ions (Figure 3) after ring opening, only the b1 and y1 
ions are missing from the expected ion series (Table 3). Most of the fragments are 
present in pairs with a mass difference of 18 Da, resulting from a possible dehydration 
at either end of the lipopeptide during the ring opening. From the y- and b-series of ions 
resulting from ring opening and dehydration at the N-terminal end, only b2, b3 and y3-6 
are found. This is in accordance with the findings of Yakimov et al 1999 (Yakimov et 
al.,  1999). y6 after dehydration at the N-terminal end, m/z 685.45, is by far the most 
abundant fragment ion from all precursors and represents the peptide moiety after ring 
opening and loss of the fatty acid chain and AA1 (Hue et al. 2001, Yakimov et al., 
1999). The elucidated amino acid sequence for all three major peaks was the same: Gln 
– Leu/Ile  - Leu/Ile – Val – Asp – Leu/Ile – Leu/Ile. This is indeed the established 
structure for lichenysin A; henceforth we will name the peaks C13-lichenysin (m/z 
1007), C14-lichenysin (m/z 1021) and C15-lichenysin (m/z 1035).  
 As shown in Figure 2, there are two major peaks of about the same intensity 
from C14-lichenysin as opposed to the other three lichenysin isoforms that only show 
one major peak each. The product ion mass spectra from the two C14-lichenysin peaks 
labelled A and B (Figure 4) reveal the occurrence of an amino acid substitution where 
leucine in position AA7 has been substituted with valine in the second peak, 1021 B. 
The overall m/z of the isoform remains the same as for 1021 A, meanwhile the rest of 
the amino acid sequence remains the same; hence the fatty acid chain has gained one 
methyl group. This substitution has been reported earlier (Zhang et al., 2014), also for 
surfactin (Peypoux et al. 1991). However, here the product ion scan from precursor 
1021 B shows that the fragment m/z 685 is also present alongside m/z 671.This suggests 
that peak 1021 B is comprised of two different lichenysin isoforms that have the same 
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retention properties on the C18 column, despite structural differences. This might be 
because the alterations only involves the addition and removal of two methyl groups, as 
opposed to the substitution of glutamine with glutamic acid in surfactin that leads to as 
much as two minutes reduction of the retention time. The product ion spectra of m/z 
1021 A and B from all 53 B. licheniformis strains reveals a similar pattern: Peak A only 
contains the common lichenysin A amino acid sequence, while peak B contains a 
mixture of the AA7 leucine and AA7 valine isoforms, but in different ratios ranging 
from 50 % to 220 %. Overall, the production of the same lichenysin isoforms from all 
53 bacterial strains investigated indicates that the growth conditions have a greater 
influence on which isoforms are produced than the genotype. This is in accordance with 
the findings of Li et al (Li et al., 2008) who found that B. licheniformis strain HSN221 
produced different lichenysin homologues when grown in different media. The AA7 
valine isoforms of lichenysin might also be present for the m/z 993, 1007 and 1035 
isoforms, but due to low-intensity second peaks they have not been considered for 
structural determination. 
Quantification with surfactin and lichenysin as calibration standards   
Each of the four major isoforms of lichenysin was quantified separately. Since it is not 
known whether all isoforms are equally potent it is in general the total lichenysin 
concentration that is of interest. The certified amount of lipopeptide in commercially 
available lichenysin and surfactin is also given as the total amount, it is important to 
note that the distribution between the different isoforms present might differ.  
  Lichenysin has recently become commercially available and was used for 
calibration for the first time. Until now, surfactin (Madslien et al.,  2013) and 
presumably in-house purified lichenysin (Zhang and Wu, 2014) have been used as 
calibration standard for lichenysin quantification. Surfactin and lichenysin are very 
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similar in structure (Figure 1) differing only with 1 Da in their molecular masses; hence 
they appear to be good calibrants for each other. However, the substitution of glutamic 
acid with glutamine at AA1 alters the physicochemical properties of the molecules as 
illustrated by the difference in their surface tension characteristics (Grangemard et al., 
1999). Consequently they might be affected differently during the sample preparation 
and not be prone to the same matrix effects during the analysis on the LC-MS, the latter 
also due to the differences in retention times. These differences in retention times are 
what make surfactin a possible calibration standard for lichenysin: If they co-eluted it 
would be impossible to differentiate between the monoisotopic mass of surfactin and 
the first isotopic mass of lichenysin. To evaluate the suitability of surfactin as 
calibration standard for lichenysin we calculated the lichenysin content in twelve 
samples spiked with 10 µg/g lichenysin with pure solvent standards of both surfactin 
and lichenysin as calibrants (Table 4). The measured concentrations were 50 – 70 % 
lower with surfactin as calibrant compared to lichenysin as calibrant (Table 4). This 
reveals a substantial underestimation of the lichenysin concentration when surfactin is 
used as calibration standard.  
Both lichenysin m/z 1021 Da and surfactin m/z 1022 Da are double peaks. As 
shown through the structural determination, these peaks are representing different 
isoforms of lichenysin but only one isoform of surfactin (data not shown). 
Consequently, the quantification of lichenysin with surfactin is a challenge for 
lichenysin m/z 1021.  Not only because of the different isoforms, but also due to the 
difference in peak intensity: for surfactin the first peak is the less intense, while the first 
peak is the most intense for lichenysin (Figure 5). This pattern is seen in lichenysin 
produced from all 53 strains included in the study: the ratio between C14-lichenysin A 
and B varies but C14-lichenysin A is always the most intense. To overcome this 
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challenge we have earlier chosen to integrate and quantify these peaks as one (Madslien 
et al.,  2013). However, the structure elucidation performed in this study revealed that 
the two peaks represent different isoforms; hence they should be quantified separately. 
The negative trueness found for m/z 1021 B with surfactin as calibration standard 
(Table 4) emphasises the shortcoming of surfactin as calibration standard for this 
lichenysin isoform.  
Quantification with pure solvent standards and matrix matched calibration.  
Quantification against a matrix matched calibration curve yields about 20 % higher 
lichenysin concentrations than calculated against pure solvent standards (Table 4). This 
demonstrates the significance of matrix matched calibration. In some cases, for instance 
at high concentration levels, it is necessary to dilute the samples to get within the 
concentration range of the calibration curve. A desirable side effect is the removal of 
possible matrix effects through dilution, and thus eliminating the difference between 
matrix matched calibration and calibration against pure solvent standards. The ratio was 
93 % to 101 % (n = 7) between the two calibration techniques when both samples and 
calibration samples were diluted 100 times before injection on the LC-MS/MS (with 
surfactin as standard). This implies that in cases where the samples have to be diluted 
hundred times due to high concentration levels of lichenysin, the most correct result will 
be achieved from calibration against pure solvent standard instead of undiluted matrix 
matched standards.   
Matrix matched calibration with surfactin as calibrant was carried out with B. 
licheniformis NVH 1079 grown according to protocol as sample matrix; hence the 
calibration samples all contained lichenysin as well. As mentioned earlier, a small peak 
with m/z 1035 eluted at the same time as C15-surfactin with m/z 1036. This is another 
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disadvantage for surfactin as calibrant for lichenysin but poses no difficulties for the 
selectivity of lichenysin as the monoisotopic mass is 1 Da lower than for surfactin. 
Surfactin as internal standard 
Zhang et al (Zhang et al., 2014) used C15-surfactin (m/z 1036) as an internal standard 
for the quantification of lichenysin.  We find that C15-surfactin coelutes with a low-
intensity peak representing an isoform of C15-lichenysin in extracts from B. 
licheniformis. These two peaks are isobaric and not separable in the mass spectrometer; 
hence C15-surfactin is not suitable for use as internal standard for lichenysin when 
several strains are being investigated. It would be possible to use one of the other 
surfactin isoforms as internal standard for all lichenysin isoforms but that would neither 
compensate possible matrix effects occurring at different retention times, nor variations 
throughout the sample preparation due to their different physicochemical properties. 
The validation data from this study shows that variation in extraction efficiency and 
matrix effects that are influencing the lichenysin isoforms differently are a higher 
contribution to the RSD than variation between samples due to common influences on 
all isoforms, for instance sampl  loss during the sample preparation. The best solution 
to overcome this challenge and improve the precision and trueness of the method would 
be to implement isotopically labelled internal standards for each lichenysin isoform.     
Validation of the quantitative LC-MS/MS method 
For all lichenysin isoforms, the most abundant fragment ion was chosen for the 
quantitative ion transition. The qualitative ion transition was chosen not only according 
to abundance, but also considering precision. For m/z 1021 B, neither the quantitative 
nor the qualitative fragment ion is present in the second isoform comprising the peak; 
subsequently only the AA7 leucine isoform is quantified.  
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We have earlier shown that all of the 53 B. licheniformis strains tested contained 
the lichenysin syntethase gene (lchAA) and produced lichenysin, including strains 
thought to be non-producers such as ATCC 14580 (Madslien et al.,  2013). This is 
probably due to our prolonged growth period; ten days as opposed to the 24 hours used 
by Wu et al.,  (2015). As a result, none of the B. licheniformis strains could be used as 
negative control. To ensure the calibration samples did not contain any lichenysin 
another Bacillus sp., Bacillus cereus ATCC 14579, was grown according to protocol 
and used as negative control and blank matrix for the calibration samples.  
The linearity was evaluated through the regression coefficient, R2, and the 
response factor test (Table 5). The coefficient of determination, R2, was ≥ 0.99 both 
with and without 1/x- weighting for all ion transitions except m/z 1035 - 685 and m/z 
1035 - 240. This is the most sensitive precursor ion; hence the highest calibration point 
at 500 µg/g yields counts around the saturation limit of the detector. Without this level, 
with 1/x-weighting, R2 is 0.995 and 0.994 for the ion transitions m/z 1035 – 685 and 
m/z 1035 – 240, respectively. The response factor test was < 15 % for all ion 
transitions. Six matrix samples without lichenysin were used to evaluate the selectivity; 
no interferences were discovered at the retention times of the analytes. For all three 
precursors m/z 1007, 1021 A and 1021 B, the LOQ is higher for the qualitative ion 
transitions than the one used for quantification (Table 5). This is as expected as the 
qualitative ion transitions are the least sensitive. With this method the LODs are all 
below 1 µg/g. If necessary, the injection volume can be increased to achieve a higher 
sensitivity. We have tried this without difficulties during the method development (data 
not shown).  
Without a suitable internal standard, it was not possible to determine the 
reproducibility of the method. The samples deteriorate rapidly both when stored at room 
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temperature, + 4°C and - 21°C; hence without an internal standard to compensate for 
the variation in storage time, the RSDs are above acceptable levels when validation 
samples from different days are compared. As a consequence, the precision was 
evaluated through the repeatability in three sample sets prepared separately but within 
the same day by the same analyst. The RSD at 10 µg/g was between 10 % and 16 % (n 
= 12). The ion ratio of m/z 1021 B is 0.50 with an RSD of 15 %, whereas the remaining 
ion ratios are well within the limits stated in EC/657/2002 (Table 5). The retention times 
of all ion transitions in the samples are well within 2.5 % of the retention time of the 
standard; hence the requirement from EC/657/2002 is achieved.  
According to EC/657/2002, the trueness should be within 80 – 110 %. Due to 
the lack of a certified reference material, the trueness was evaluated by spiking blank 
matrix samples with a known amount of lichenysin. The results are given for each ion 
transition in Table 5, ranging from 67 % to 121 % overall (n = 12). Both ion transitions 
from precursor ion m/z 1035 show the best trueness; 77 – 109 % and 79 – 113 %, 
respectively, but also these are slightly outside the limits. The poor trueness of the 
method is most likely a result of varying matrix effects and sample loss throughout the 
analysis. Careful studying of each measurement reveals that the different lichenysin 
isoforms are not influenced in the same way in each sample: The ratio in trueness 
ranges from 80 % to 111 % between two single measurements for the different 
lichenysin isoforms. Implementation of isotopically labelled internal standards 
representing each lichenysin isoform would probably improve the trueness of the 
method.  
The total recovery of the method, RT, was 74 % to 83 %. This is a result of the 
rapid and simple sample preparation; about one third of the lichenysin was lost during 
the extraction as shown through the RSP ranging from 57 % to 68 %. The RMS from 
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111% to 142 % indicates a signal enhancement that reduces the effect of the analyte loss 
during the sample preparation. A total recovery less than 100 % emphasises the 
importance of matrix matched calibration where the calibration samples undergoes the 
same extraction procedure as the unknown samples.  
Biomass from 18 plates of Bacillus licheniformis strain NVH1079, a known 
lichenysin producer (Madslien et al., 2013)  was pooled to achieve a homogenous 
sample material to be used as a positive control. The RSD (n = 21) was 30 % for C12-
lichenysin, 18 % for C13-lichenysin, 16 % for C14-lichenysin A and B and 12 % for 
C15-lichenysin when samples prepared on three different days within one month were 
calculated together. Within each day (n = 7) the RSDs ranged from 4 - 8 %, 6 - 10 % 
and 16 - 23 %, without C12-lichenysin. This indicates that the highest contribution to 
the deviation is day-to-day variations and that the homogeneity of the sample material is 
satisfactory. 
Conclusion 
Lichenysin produced by 53 different B. licheniformis strains has been qualitatively 
examined. All strains produced the same lichenysin isoforms but in varying ratios. This 
indicates that lichenysin production is indeed more dependent on growth conditions 
than genotype. By introducing commercially available lichenysin as calibration standard 
and perform a complete validation study based on Commission Decision 657, we have 
refined a quantitative analytical method that ensures more accurate quantification of 
lichenysin in bacterial cell extracts.  
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Table 1: Targeted precursors for product ion scan for qualitative LC-MS/MS analysis 
on LC-Q-TOF 
 Precursor m/z Retention 
time (min) 
Lichenysin 
993.65 4.8 
1007.67 5.7 
1021.68 7.0 and 7.5  
1035.70 8.6 
Surfactin 
994.64 3.7 
1008.65 4.3 
1022.67 5.4 and 5.7 
1036.68 6.7 
 
Table 2: Ion transitions monitored and their corresponding collision energies for 
quantitative LC-MS/MS analysis on LC-QqQ 
 Precursor m/z Product m/z CE (eV) Retention 
time (min) 
Lichenysin 
993.4 685.2 40 3.3 
993.4 535.4 40 3.3 
1007.7 685.4 40 3.8 
1007.7 441.1 40 3.8 
1021.7 685.4 40 4.6 and 4.8 
1021.7 581.3 40 4.6 and 4.8 
1035.7 685.3 20 5.5 
1035.7 240.1 80 5.5 
Surfactin 
994.6 685.2 30 2.6 
994.6 441.2 40 2.6 
1008.6 685.2 30 3.0 
1008.6 441.2 40 3.0 
1022.6 685.2 30 3.6 and 3.8 
1022.6 201.0 80 3.6 and 3.8 
1036.6 685.3 30 4.4 
1036.6 227.2 50 4.4 
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Table 3: y- and b- ions found after ring opening and fragmentation of the peptide moiety 
of lichenysin. The first fragments are resulting from dehydration at the C-terminal end 
and the second fragments are products of dehydration at the N-terminal end. The 
fragments in brackets are from m/z 1021.68 B with valine in the AA7 position. 
Ions found m/z 1007.67 m/z 1021.68 A m/z 1021.68 B m/z 1035.70 
b1 - 227 227 - 
b2 341 / 323 355 / 337 355 / 337 (369) 369 / 351 
b3 454 / 436 468 / 450 468 / 450 (482) 482 / 464 
b4 567 581 581 (595) 595 / 578 
b5 666 680 680 (694) 694 
b6 781 795 795 (809) 809 
b7 894 908 908 (922) 922 
y2 227 227 227 227 
y3 342 / 360 342 / 360 342 / 360 342 / 360 
y4 441 / 459 441 / 459 441 / 459 (445) 441 / 459 
y5 554 / 572 554 / 572 554 / 572 554 / 572 
y6 667 / 685 667 / 685 667 / 685 (671) 667 / 685 
y7 795 795 795 - 
 
 
Table 4: Average trueness (%) of lichenysin (concentration 10 µg/g, n = 12) quantified 
against pure solvent standards of surfactin and lichenysin, and matrix matched 
calibration with lichenysin. The RSDs are given in brackets.   
Ion transition Surfactin,  
pure solvent  
Lichenysin,  
pure solvent 
Lichenysin,  
matrix matched 
1007 – 685 20 (9) 68 (10) 89 (10) 
A 1021 – 685 38 (5) 70 (12) 89 (12) 
B 1021 – 685 -0.2 (-4) 67 (14) 89 (16) 
1035 – 685 30 (12) 74 (11) 94 (11) 
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Table 5: Results of the validation calculated from three different sample sets and a total 
of 30 samples. LOD, LOQ and trueness are calculated with 1/x-weighting in linear 
regression. (The numbers in square brackets are calculated without + 500 µg/g.) 
Ion 
transiti
on 
R2 R2 
With 
1/x-
weighti
ng 
 
LOD 
(µg/g)
LOQ 
(µg/g) 
Respo
nse 
factor 
test 
(%) 
Repea
tability 
RSD 
(%) 
n = 12 
ΔRT 
(%) 
n = 30 
Ion ratio 
(RSD %) 
n = 21 
Trueness 
(%) 
n = 12 
993 – 
685* 
0.973 0.854 - 4.0 17 60 67 2.1 4.2 (127) -116 – 70 
1007 – 
685 
0.994 0.993 0.4 1.0 12 10 0.2 
0.37 (14) 
72 – 102 
1007 - 
441 
0.990 0.991 -0.1 2.5 14 
 
16 0.3 67 – 117 
A 1021 
– 685 
0.993 0.992 0.5 0.9 14 12 0.2  
0.35 (9) 
70 – 103 
A 1021 
– 581 
0.991 0.992 0.5 1.0 13 13 0.2 83 – 121 
B 1021 
– 685 
0.991 0.992 0.2 1.7 14 15 0.2 
0.50 (15) 
68 – 113 
B 1021 
– 581 
0.995 0.994 
 
0.8 2.1 13 13 0.3 79 – 121 
1035 – 
685 
0.992 0.987 
[0.995 ] 
- 0.1 1.2 12 10 0.2 
0.79 (5) 
77 – 109 
[70 – 98] 
1035 - 
240 
0.991 0.986 
[0.996] 
-0.3 0.5 13 12 0.2 79 – 113 
[71 – 100] 
* The ion transition m/z 993 – 685 is only qualitative due to low content in the calibration 
standard.  It is included in the table for information only.  
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Figure 1: Molecular structure of lichenysin A (monoisotopic mass 1020, R = NH2) and 
surfactin (monoisotopic mass 1021, R = OH), differing only with a glutamine 
(lichenysin) / glutamic acid (surfactin) substitution at amino acid position AA1. 
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Figure 2: Extracted ion chromatograms, EIC, of the four major lichenysin isoforms 
found together with their mass spectra. (B. licheniformis ATCC 14580.) 
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Figure 3: Q-TOF mass spectrum from lichenysin precursor m/z 1007.67 (B. 
licheniformis NVH 1115). Only the b1 and y1 ions are missing from the expected 
fragment ion series resulting from a ring opening and dehydration at the C-terminal end. 
From the fragment ion-series of ions resulting from ring opening and dehydration at the 
N-terminal end, only b2-H2O and b3-H2O and y3+H20, y4+H2O, y5+H2O and y6+H2O 
are found. The latter is the most abundant fragment ion in the mass spectrum. 
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Figure 4: Product ion spectra from m/z 1021.68 A and B showing the complete b-ion 
series from the two different occurring isoforms: In m/z 1021 A is AA7 leucine, while 
in m/z 1021 B is both AA7 leucine and AA7 valine present. The most abundant 
fragment ion, y6 + H2O, represented by both m/z 671 and m/z 685 from precursor m/z 
1021 B indicates the presence of both AA7 Leu and AA7 Val isoforms, whereas it is 
only present as the AA7 Leu isoform in m/z 1021 A. 
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Figure 5: Peak intensity difference between C14-surfactin A and B and C14-lichenysin 
A and B. (Surfactin from B. subtilis and lichenysin from B. licheniformis ATCC 14580.) 
 
 
